Page last updated: 2024-10-19

2,3,4,5-tetrahydroxypentanal and Candidiasis

2,3,4,5-tetrahydroxypentanal has been researched along with Candidiasis in 1 studies

Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"The incidence of candidiasis has significantly increased globally in recent decades, and it is a significant source of morbidity and mortality, particularly in critically ill patients."1.91Evaluation of citrus pectin capped copper sulfide nanoparticles against Candidiasis causing Candida biofilms. ( Al-Enazi, NM; Alsamhary, K; Ameen, F, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Al-Enazi, NM1
Alsamhary, K1
Ameen, F1

Other Studies

1 other study available for 2,3,4,5-tetrahydroxypentanal and Candidiasis

ArticleYear
Evaluation of citrus pectin capped copper sulfide nanoparticles against Candidiasis causing Candida biofilms.
    Environmental research, 2023, 05-15, Volume: 225

    Topics: Antifungal Agents; Biofilms; Candida; Candida albicans; Candidiasis; Copper; Microbial Sensitivity T

2023